BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
And this includes positive margins and positive lymph nodes, which, you know, it's kind of special that we included positive margins. Or they did not receive cisplatinibase neoadjuvant therapy but have a T3 or greater muscle invasive disease or positive lymph nodes or positive margins.
0
💬
0
Comments
Log in to comment.
There are no comments yet.